Basics AquaBounty Technologies, Inc. AquaBounty Technologies Inc is a biotechnology company. The company is engaged in the business of conducting research and development of the commercial viability of a group of proteins known as antifreeze proteins. IPO Date: January 9, 2017 Sector: Healthcare Industry: Biotech Market Cap: $6.28M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 4.01% Avg Daily Range (30 D): $0.12 | 6.47% Avg Daily Range (90 D): $0.07 | 4.67% Institutional Daily Volume Avg Daily Volume: .53M Avg Daily Volume (30 D): 1.2M Avg Daily Volume (90 D): 1.6M Trade Size Avg Trade Size (Sh.): 190 Avg Trade Size (Sh.) (30 D): 154 Avg Trade Size (Sh.) (90 D): 242 Institutional Trades Total Inst.Trades: 125 Avg Inst. Trade: $1.52M Avg Inst. Trade (30 D): $.52M Avg Inst. Trade (90 D): $.52M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.13M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 21.76K     News Aug 25, 2025 @ 12:00 PM Shenandoah Telecommunications Appoints Angela M. O... Source: Angela M. Olsen May 15, 2024 @ 2:20 PM AquaBounty Technologies, Inc. (AQB) Reports Q1 Los... Source: Zacks Equity Research May 14, 2024 @ 1:10 PM Immunome, Inc. (IMNM) Reports Q1 Loss, Misses Reve... Source: Zacks Equity Research May 13, 2024 @ 9:10 PM Cara Therapeutics (CARA) Reports Q1 Loss, Misses R... Source: Zacks Equity Research May 8, 2024 @ 9:45 PM Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, To... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-23.43 $-.87 $.1 Diluted EPS $-23.43 $-.87 $.1 Revenue $ -.66M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -90.49M $ -3.37M $ .4M Operating Income / Loss $ -55.53M $ -3.29M $ -1.26M Cost of Revenue $ $ $ Net Cash Flow $ M $ -.64M $ 1.14M PE Ratio     Splits Oct 16, 2023:   1:20 Jan 05, 2017:   1:30